CIK 0000897448
- Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +353 16699020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-10-31 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −2,771 | 75,311 | ||
| 2018-10-31 | Kennedy Joseph T General Counsel | Option exercise | +1,953 | $1.02 | $2K | 219,887 |
| 2018-10-31 | Kennedy Joseph T General Counsel | Option exercise | +2,604 | $1.40 | $4K | 222,491 |
| 2018-10-31 | Kennedy Joseph T General Counsel | Option exercise | +18,750 | $2.50 | $47K | 241,241 |
| 2018-10-31 | Kennedy Joseph T General Counsel | Sale | −22,707 | $20.72 | $471K | 218,534 |
| 2018-10-31 | Kennedy Joseph T General Counsel | Sale | −600 | $21.37 | $13K | 217,934 |
| 2018-10-31 | Kennedy Joseph T General Counsel | Option exercise · Stock Option (Right to Buy) | −1,953 | 5,859 | ||
| 2018-10-31 | Kennedy Joseph T General Counsel | Option exercise · Stock Option (Right to Buy) | −2,604 | 39,062 | ||
| 2018-10-31 | Kennedy Joseph T General Counsel | Option exercise · Stock Option (Right to Buy) | −18,750 | 150,010 | ||
| 2018-10-01 | Ketchum Steven B Chief Scientific Officer | Option exercise | +100,000 | $8.77 | $877K | 441,297 |
| 2018-10-01 | Ketchum Steven B Chief Scientific Officer | Option exercise | +2,771 | $2.95 | $8K | 444,068 |
| 2018-10-01 | Ketchum Steven B Chief Scientific Officer | Option exercise | +3,750 | $2.50 | $9K | 447,818 |
| 2018-10-01 | Ketchum Steven B Chief Scientific Officer | Option exercise | +3,312 | $2.50 | $8K | 451,130 |
| 2018-10-01 | Ketchum Steven B Chief Scientific Officer | Option exercise | +4,167 | $2.50 | $10K | 455,297 |
| 2018-10-01 | Ketchum Steven B Chief Scientific Officer | Option exercise | +2,604 | $1.40 | $4K | 457,901 |
| 2018-10-01 | Ketchum Steven B Chief Scientific Officer | Sale | −116,604 | $17.20 | $2.0M | 341,297 |
| 2018-10-01 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −100,000 | 0 | ||
| 2018-10-01 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −2,771 | 78,082 | ||
| 2018-10-01 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −3,750 | 33,750 | ||
| 2018-10-01 | Ketchum Steven B Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −3,312 | 64,188 |
Page 80 of 95 · 1,885 trades